HomeAKBA • NASDAQ
add
Akebia Therapeutics Inc
Previous close
$1.57
Day range
$1.52 - $1.60
Year range
$1.49 - $4.08
Market cap
427.31M USD
Avg Volume
5.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 58.77M | 57.01% |
Operating expense | 44.04M | 0.05% |
Net income | 540.00K | 102.69% |
Net profit margin | 0.92 | 101.72% |
Earnings per share | 0.00 | 100.00% |
EBITDA | 4.77M | 252.25% |
Effective tax rate | 53.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 166.44M | 389.27% |
Total assets | 364.15M | 75.80% |
Total liabilities | 322.56M | 25.24% |
Total equity | 41.59M | — |
Shares outstanding | 265.37M | — |
Price to book | 9.81 | — |
Return on assets | 3.13% | — |
Return on capital | 4.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 540.00K | 102.69% |
Cash from operations | 28.10M | 519.79% |
Cash from investing | -77.00K | -3,750.00% |
Cash from financing | 1.11M | -8.99% |
Net change in cash | 29.14M | 632.35% |
Free cash flow | 21.12M | 158.04% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
181
